InvestorsHub Logo
Followers 18
Posts 624
Boards Moderated 0
Alias Born 11/21/2014

Re: None

Tuesday, 09/22/2020 9:53:17 AM

Tuesday, September 22, 2020 9:53:17 AM

Post# of 24655
$TOMDF 10m market cap, just awarded a 47.5m contract.

https://www.globenewswire.com/news-release/2020/09/22/2097258/0/en/Todos-Medical-Expands-Existing-Contract-for-COVID-19-PCR-Testing-Equipment-Supplies-with-Wisconsin-based-Laboratory-to-47-5-Million.html

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 22, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has rapidly expanded its agreement with a Wisconsin-based laboratory to supply it with the necessary testing equipment and supplies to ramp up to 12,000 tests a day, for a total contract value of $47.5 million in reagent sales by Todos Medical over the next seven months. Todos will be supplying automated extraction machines, liquid handlers and PCR machines. Todos has also been granted a priority right to supply the lab with up to 100,000 COVID PCR tests per day in the event the laboratory sees significant additional testing demand.

“As we are now midway into the implementation phase with this client, we are seeing how increasing their testing capacity is being met with the pent up demand for PCR testing services from this client, especially from skilled nursing facilities,” said Gerald Commissiong, President & CEO of Todos. “There is tremendous nationwide demand for COVID-19 testing services and solutions in skilled nursing facilities. As we begin to make in-roads in developing this sales channel for our COVID test, we expect that we will be able to tailor programs using combinations of testing that allow for screening and diagnosis. We expect nursing homes and skilled nursing facilities to play a major part of our COVID-19 testing strategy. Additionally we believe this will pave the way for the deployment of our immune-based Alzheimer’s blood diagnostic LymPro Test™.”

For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com

For testing and PPE inquiries, please email sales@todosmedical.com.

*I probably own shares of this stock. All posts are made in my opinion only and are not investing advice.

$IFRX, $RLFTF, $RDHL

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.